skip to main content
Idioma:
Quiso decir: marina mariana?
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies
Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies
Material Type:
Artículo 		Añadir a Mi Portal

Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies

Karpen, Stephen R. ; Dunne, Jessica L. ; Frohnert, Brigitte I. ; Marinac, Marjana ; Richard, Claudia ; David, Sarah E. ; O’Doherty, Inish M.

Diabetologia, 2023-03, Vol.66 (3), p.415-424 [Revista revisada por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponible

Citas Citado por
2
284-OR: How Do Patients and Caregivers Prioritize Outcomes for Type 1 Diabetes (T1D) Treatment?
284-OR: How Do Patients and Caregivers Prioritize Outcomes for Type 1 Diabetes (T1D) Treatment?
Material Type:
Artículo 		Añadir a Mi Portal

284-OR: How Do Patients and Caregivers Prioritize Outcomes for Type 1 Diabetes (T1D) Treatment?

MARINAC, MARJANA ; HUTTON, CAMPBELL T. ; MANSFIELD, CAROL ; SUTPHIN, JESSIE ; GALLAHER, KATHLEEN ; SULLIVAN, SEAN

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1) [Revista revisada por pares]

New York: American Diabetes Association

Texto completo disponible

Citas Citado por
3
182-OR: C-Peptide and Metabolic Outcomes in Immunotherapy Studies of New-Onset Type 1 Diabetes
182-OR: C-Peptide and Metabolic Outcomes in Immunotherapy Studies of New-Onset Type 1 Diabetes
Material Type:
Artículo 		Añadir a Mi Portal

182-OR: C-Peptide and Metabolic Outcomes in Immunotherapy Studies of New-Onset Type 1 Diabetes

TAYLOR, PETER ; COLLINS, KIMBERLY S. ; KARPEN, STEPHEN ; ATABAKHSH, ELNAZ ; AHMED, SIMI ; MARINAC, MARJANA ; LATRES, ESTHER ; LAM, ANNA ; SENIOR, PETER A. ; RIGBY, MARK ; GOTTLIEB, PETER ; DAYAN, COLIN

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1 [Revista revisada por pares]

New York: American Diabetes Association

Texto completo disponible

Citas Citado por
4
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop
Material Type:
Artículo 		Añadir a Mi Portal

Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop

Rickels, Michael R ; Stock, Peter G ; de Koning, Eelco J.P ; Piemonti, Lorenzo ; Pratschke, Johann ; Alejandro, Rodolfo ; Bellin, Melena D ; Berney, Thierry ; Choudhary, Pratik ; Johnson, Paul R ; Kandaswamy, Raja ; Kay, Thomas W.H ; Keymeulen, Bart ; Kudva, Yogish C ; Latres, Esther ; Langer, Robert M ; Lehmann, Roger ; Ludwig, Barbara ; Markmann, James F ; Marinac, Marjana ; Odorico, Jon S ; Pattou, François ; Senior, Peter A ; Shaw, James A.M ; Vantyghem, Marie-Christine ; White, Steven

Transplantation, 2018-09, Vol.102 (9), p.1479-1486 [Revista revisada por pares]

United States: Copyright Wolters Kluwer Health, Inc. All rights reserved

Texto completo disponible

Citas Citado por
5
Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
Material Type:
Artículo 		Añadir a Mi Portal

Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes

Anderson, Randy L ; DiMeglio, Linda A ; Mander, Adrian P ; Dayan, Colin M ; Linsley, Peter S ; Herold, Kevan C ; Marinac, Marjana ; Ahmed, Simi T

Diabetes care, 2022-10, Vol.45 (10), p.2189-2201 [Revista revisada por pares]

United States: American Diabetes Association

Texto completo disponible

Citas Citado por
6
Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189-2201
Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189-2201
Material Type:
Artículo 		Añadir a Mi Portal

Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189-2201

Anderson, Randy L ; DiMeglio, Linda A ; Mander, Adrian P ; Dayan, Colin M ; Linsley, Peter S ; Herold, Kevan C ; Marinac, Marjana ; Ahmed, Simi T

Diabetes care, 2022-12, Vol.45 (12), p.3113-3113 [Revista revisada por pares]

United States: American Diabetes Association

Texto completo disponible

Citas Citado por
7
Defining outcomes for β‐cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop
Defining outcomes for β‐cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop
Material Type:
Artículo 		Añadir a Mi Portal

Defining outcomes for β‐cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop

Rickels, Michael R. ; Stock, Peter G. ; Koning, Eelco J. P. ; Piemonti, Lorenzo ; Pratschke, Johann ; Alejandro, Rodolfo ; Bellin, Melena D. ; Berney, Thierry ; Choudhary, Pratik ; Johnson, Paul R. ; Kandaswamy, Raja ; Kay, Thomas W. H. ; Keymeulen, Bart ; Kudva, Yogish C. ; Latres, Esther ; Langer, Robert M. ; Lehmann, Roger ; Ludwig, Barbara ; Markmann, James F. ; Marinac, Marjana ; Odorico, Jon S. ; Pattou, François ; Senior, Peter A. ; Shaw, James A. M. ; Vantyghem, Marie‐Christine ; White, Steven

Transplant international, 2018-04, Vol.31 (4), p.343-352 [Revista revisada por pares]

England: Blackwell Publishing Ltd

Texto completo disponible

Citas Citado por
8
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
Material Type:
Artículo 		Añadir a Mi Portal

C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis

Taylor, Peter N ; Collins, Kimberly S ; Lam, Anna ; Karpen, Stephen R ; Greeno, Brianna ; Walker, Frank ; Lozano, Alejandro ; Atabakhsh, Elnaz ; Ahmed, Simi T ; Marinac, Marjana ; Latres, Esther ; Senior, Peter A ; Rigby, Mark ; Gottlieb, Peter A ; Dayan, Colin M

The lancet. Diabetes & endocrinology, 2023-12, Vol.11 (12), p.915-925 [Revista revisada por pares]

England

Texto completo disponible

Citas Citado por
9
Preferences for Outcomes Among Adults with Type 1 Diabetes and Caregivers of Children with Type 1 Diabetes
Preferences for Outcomes Among Adults with Type 1 Diabetes and Caregivers of Children with Type 1 Diabetes
Material Type:
Artículo 		Añadir a Mi Portal

Preferences for Outcomes Among Adults with Type 1 Diabetes and Caregivers of Children with Type 1 Diabetes

Marinac, Marjana ; Sutphin, Jessie ; Hutton, Campbell ; Klein, Kathleen ; Sullivan, Sean ; Mansfield, Carol

Patient preference and adherence, 2020-01, Vol.14, p.1719-1731 [Revista revisada por pares]

New Zealand: Taylor & Francis Ltd

Texto completo disponible

Citas Citado por
10
Evidence for C-peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes
Evidence for C-peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes
Material Type:
Artículo 		Añadir a Mi Portal

Evidence for C-peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes

Latres, Esther ; Greenbaum, Carla J ; Oyaski, Maria L ; Dayan, Colin M ; Colhoun, Helen M ; Lachin, John M ; Skyler, Jay S ; Rickels, Michael R ; Ahmed, Simi T ; Dutta, Sanjoy ; Herold, Kevan C ; Marinac, Marjana

Diabetes (New York, N.Y.), 2024-02 [Revista revisada por pares]

United States

Texto completo disponible

Citas Citado por

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Fecha de Publicación 

De Hasta
Refinar
  1. Antes de2018  (1)
  2. 2018Hasta2018  (2)
  3. 2019Hasta2019  (1)
  4. 2020Hasta2022  (3)
  5. Después de 2022  (4)
  6. Más opciones open sub menu

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora